Abstract
The role of gastrin in the growth of gastrointestinal tumours is complex, involving both endocrine and autocrine/paracrine pathways. Receptor subtypes, distinct from the classical gastrin/CCK-B receptors which mediate the normal physiological functions of gastrin, are now being identified. These appear to have potential roles in gastrin-associated proliferative pathways in malignant cells. Due to the recent expansion of knowledge in this area, the role of the classical anti-gastrin agents remains unclear. This is especially so for the gastrin/CCK-B receptor antagonists, due to the multiple receptor types now in evidence. However, certain agents may potentially overcome the problem of the different gastrin-mediated mitogenic pathways and the receptor isoforms involved. Although agents which block gastrin secretion, such as somatostatin analogues, might have been expected to be successful at targeting the autocrine/paracrine pathway, clinically, in gastrointestinal adenocarcinomas, they have proven disappoi...
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
